TOI | The Oncology Institute, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.2717 - 0.3155
52 Week Range	0.2717 - 2.6550
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	107,210
Average Volume	125,395
Shares Outstanding	75,490,500
Market Cap	21,137,340
Sector	Healthcare
Industry	Medical - Care Facilities
IPO Date	2020-06-04

Valuation
Profitability
Growth
Health
P/E Ratio	-0.35
Forward P/E Ratio	N/A
EPS	-0.79
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	800
Country	USA
Website	TOI

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

TOI's peers: AIRS, AMS, ATIP, NVOS, CCM, CCEL, RHE, RMYHY, MFCSF, JNHMF, MCIOF, FSNUY, CANO, LFST, AGL, PNTG, BKD, SGRY, SEM, ENSG, MD, UHS, ADUS, EHC, SNDA, JYNT, TOIIW, BACK

*Chart delayed

Analyzing fundamentals for TOI we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is very weak. For more detailed analysis please see TOI Fundamentals page.

Watching at TOI technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on TOI Technicals page.